相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 服务名称:
大肠杆菌系统重组蛋白表达
- 提供商:
普健生物(武汉)科技有限公司
Uniprot号:Q8C159
基因名:Ttc22
蛋白名:Tetratricopeptide repeat protein 22
蛋白别名:
Tetratricopeptide repeat protein 22, TPR repeat protein 22
服务内容:
| 服务项目 | 客户提供 | 服务内容 | 服务周期 | 交付内容 |
|---|---|---|---|---|
| 大肠杆菌系统 蛋白表达 |
基因序列 | 方案沟通 | 1天 | 方案报告 |
| 密码子优化和基因合成 | 5天 | 基因合成报告 | ||
| 表达纯化测试 | 3天 | 表达纯化测试报告 | ||
| 1L表达及纯化 | 3天 | 蛋白样品(3-5mg)及报告 | ||
| 放大发酵及纯化 | 7天 | 纯化的蛋白及报告 |
案例展示:

Ttc22相关研究文献:
1. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern. [35798874]
2. TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition. [38034483]
3. miR663a‑TTC22V1 axis inhibits colon cancer metastasis. [30664167]
4. Integrating DNA sequencing and transcriptomic data for association analyses of low-frequency variants and lipid traits. [31919517]
5. The impact of Yiwei decoction on the LncRNA and CircRNA regulatory networks in premature ovarian insufficiency. [37809621]
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验2. TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition. [38034483]
3. miR663a‑TTC22V1 axis inhibits colon cancer metastasis. [30664167]
4. Integrating DNA sequencing and transcriptomic data for association analyses of low-frequency variants and lipid traits. [31919517]
5. The impact of Yiwei decoction on the LncRNA and CircRNA regulatory networks in premature ovarian insufficiency. [37809621]
技术资料暂无技术资料 索取技术资料









